These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9482918)

  • 1. Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent.
    Manuelidis L
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2520-5. PubMed ID: 9482918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated Creutzfeldt-Jakob Disease agents can hide more virulent infections.
    Manuelidis L; Yun Lu Z
    Neurosci Lett; 2000 Nov; 293(3):163-6. PubMed ID: 11036186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.
    Manuelidis L; Lu ZY
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5360-5. PubMed ID: 12692308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent.
    Sakaguchi S; Katamine S; Shigematsu K; Nakatani A; Moriuchi R; Nishida N; Kurokawa K; Nakaoke R; Sato H; Jishage K
    J Virol; 1995 Dec; 69(12):7586-92. PubMed ID: 7494265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
    Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
    Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.
    Manuelidis L; Zaitsev I; Koni P; Lu ZY; Flavell RA; Fritch W
    J Virol; 2000 Sep; 74(18):8614-22. PubMed ID: 10954563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures.
    Nishida N; Katamine S; Manuelidis L
    Science; 2005 Oct; 310(5747):493-6. PubMed ID: 16239476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease and scrapie prions.
    Prusiner SB
    Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease.
    Miyazawa K; Kipkorir T; Tittman S; Manuelidis L
    PLoS One; 2012; 7(4):e35471. PubMed ID: 22509412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.
    Manuelidis L; Liu Y; Mullins B
    J Cell Biochem; 2009 Feb; 106(2):220-31. PubMed ID: 19097123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.
    Miyazawa K; Emmerling K; Manuelidis L
    Virulence; 2011; 2(3):188-99. PubMed ID: 21527829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
    Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
    Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the abnormal prion protein during coinfection of mice by bovine spongiform encephalopathy and a scrapie agent.
    Baron TG; Biacabe AG
    J Virol; 2001 Jan; 75(1):107-14. PubMed ID: 11119579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of I137M and other mutations that modulate incubation periods for two human prion strains.
    Giles K; De Nicola GF; Patel S; Glidden DV; Korth C; Oehler A; DeArmond SJ; Prusiner SB
    J Virol; 2012 Jun; 86(11):6033-41. PubMed ID: 22438549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.